[Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
Service de Gynécologie Obstétrique, CHI Poissy-Saint-Germain, BP 3082, 10, rue de Champ-Gaillard, 78303 Poissy Cedex.
M V
MV
Senat
P
P
Rozenberg
J P
JP
Bernard
Y
Y
Ville
D000465:Algorithms; D015415:Biomarkers / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood*; D003663:Decision Trees; D004314:Down Syndrome / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology; D004964:Estriol / Q000097:blood*; D005260:Female; D005865:Gestational Age; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008423:Maternal Age; D018579:Patient Selection; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011266:Pregnancy-Associated Plasma Protein-A / Q000378:metabolism*; D011296:Prenatal Diagnosis / Q000379:methods*; D015203:Reproducibility of Results; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016216:Ultrasonography, Prenatal / Q000379:methods*; D000509:alpha-Fetoproteins / Q000378:metabolism*
D015415:Biomarkers; D018997:Chorionic Gonadotropin, beta Subunit, Human; D000509:alpha-Fetoproteins; D011266:Pregnancy-Associated Plasma Protein-A; D004964:Estriol